Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Active not recruiting 2Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Uterine Cervical Neoplasms 1Neoplasm Metastasis 1

Interventions

Pemetrexed 18Carboplatin 16Cisplatin 14Paclitaxel 9Gemcitabine 7pembrolizumab 6Crizotinib 5osimertinib 4amivantamab 4Nivolumab 4Docetaxel 4lazertinib 3Vinorelbine 3Ipilimumab 3Afatinib 3selpercatinib 2lorlatinib 2durvalumab 2cemiplimab 2atezolizumab 2alectinib 2Gefitinib 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zenocutuzumab 1trastuzumab deruxtecan 1trametinib 1tepotinib 1telisotuzumab vedotin 1taletrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has announcements × Carcinoma, Non-Small-Cell Lung × Vinorelbine × Clear all
NCT03456076 2026-05-05

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 3 Active not recruiting
257 enrolled 14 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02486718 2026-04-30

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

Hoffmann-La Roche

Phase 3 Active not recruiting
1,280 enrolled 24 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02998528 2026-01-06

CheckMate 816

Bristol-Myers Squibb

Phase 3 Completed
505 enrolled 17 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡